Found 6 matching trials
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
PHASE1This phase I trial studies the side effects, best way to give, and best dos...
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer
PHASE1Study IPI-504-15 is a Phase 1b/2 clinical trial to evaluate the safety and ...
Location
University of Colorado Denver
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
PHASE2Phase II trial to study the effectiveness of gemcitabine hydrochloride and ...
Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib
PHASE3IPI-504-06 is a Phase 3, randomized, double-blind, placebo-controlled, mult...
Location
Multiple Locations
17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors
PHASE1This phase I trial is studying the side effects and best dose of 17-AAG and...
Location
Memorial Sloan Kettering Cancer Center
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer
PHASE2This randomized phase II trial is studying three different schedules of gem...